Quantum BioPharma Ltd.
QNTM
$3.02
-$0.34-9.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.18M | -28.51M | -27.02M | -20.88M | -14.20M |
| Total Depreciation and Amortization | 545.80K | 529.20K | 504.70K | 500.10K | 490.50K |
| Total Amortization of Deferred Charges | 1.49M | 1.49M | 1.49M | -- | -- |
| Total Other Non-Cash Items | 13.92M | 9.02M | 7.33M | 614.90K | -2.92M |
| Change in Net Operating Assets | 1.99M | 8.70M | 7.19M | 10.60M | 9.76M |
| Cash from Operations | -8.24M | -8.77M | -10.51M | -9.16M | -6.88M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.95M | -1.06M | -4.93M | -2.83M | -1.50M |
| Cash from Investing | -1.95M | -1.06M | -4.93M | -2.83M | -1.50M |
| Total Debt Issued | 5.36M | 6.36M | 5.78M | 3.84M | 1.01M |
| Total Debt Repaid | -1.61M | -882.40K | -876.80K | -72.30K | -63.70K |
| Issuance of Common Stock | 529.70K | 1.68M | 8.72M | 10.42M | 10.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.82M | -- | -- | -- | -- |
| Cash from Financing | 6.10M | 7.15M | 13.63M | 14.18M | 11.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.09M | -2.67M | -1.81M | 2.19M | 3.24M |